EUVIMEDEUVIMED entdecken
Leserbrief

Paternal and Maternal Metformin Use and the Risk for Major Congenital Malformations

Sarah Martins da Silva

Annals of Internal Medicine · 2024

DOI: 10.7326/m24-0883 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Annals of Internal Medicine, 2024. Verfasst von Sarah Martins da Silva. Beteiligte Einrichtung: Reproductive Medicine Research Group, School of Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom. Hauptthemen laut MEDLINE: Metformin, Hypoglycemic Agents, Abnormalities, Drug-Induced. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminHypoglycemic AgentsAbnormalities, Drug-InducedHumansFemalePregnancyMaleRisk FactorsAdultPaternal ExposurePrenatal Exposure Delayed EffectsInfant, Newborn

Substanzen

MetforminHypoglycemic Agents

Autor:innen und Institutionen

  • Reproductive Medicine Research Group, School of Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom.

Zitieren

APA

Martins da Silva, S. (2024). Paternal and Maternal Metformin Use and the Risk for Major Congenital Malformations. Annals of Internal Medicine. https://doi.org/10.7326/m24-0883

Vancouver

Martins da Silva S. Paternal and Maternal Metformin Use and the Risk for Major Congenital Malformations. Annals of Internal Medicine. 2024. doi:10.7326/m24-0883

BibTeX
@article{MartinsdaSilva2024,
  author = {Martins da Silva, Sarah},
  title = {Paternal and Maternal Metformin Use and the Risk for Major Congenital Malformations},
  journal = {Annals of Internal Medicine},
  year = {2024},
  doi = {10.7326/m24-0883}
}
Kostenlos starten →